Handelsavisen
prelaunch
Companies Healthcare VICP.SI
VI
VICP.SI SGX Medical Equipment, Supplies & Distribution

Vicp.Si

$0,09
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
0,1 %
ROE
-3,3 %
Net margin
-2,0 %
Debt / equity
0,58
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

VICP.SI operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

Business. VICP.SI operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-3,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning VICP.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to VICP.SI. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    VICP.SI operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    The company's capital structure shows a debt-to-equity ratio of 0.58, indicating a moderate level of leverage. However, its liquidity position is assessed as medium, with a current ratio of 1.46, suggesting that the company has sufficient short-term assets to cover its short-term liabilities, but not with a large margin of safety. The company's cash and equivalents amount to SGD 4.714 million, which is significantly lower than its long-term debt of SGD 41.112 million, resulting in a negative net cash position.

    In terms of profitability, the company reported a net loss of SGD 2.357 million, with a return on equity of -3.3% and a return on assets of -1.71%. These figures are below the industry median for profitability metrics, indicating that the company is underperforming relative to its peers in terms of generating returns for shareholders and utilizing its assets efficiently.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher risks if demand in its primary market or product line declines.

    The company's growth trajectory is uncertain, as the available data does not provide forward-looking revenue projections or historical growth rates. The negative net income and the absence of positive free cash flow suggest that the company is not currently generating sufficient cash to fund its operations and capital expenditures without external financing.

    The company's risk assessment indicates a low potential for dilution, with no significant dilution events reported in the available data. However, the company's liquidity risk is assessed as medium, primarily due to its negative net cash position and the need to service its long-term debt.

    Recent events, including filings and transcripts, are not detailed in the available data, making it difficult to assess the company's recent performance and strategic direction. The company's financial statements do not provide information on recent management discussions or significant business developments.

    Key takeaways
    • The company has a moderate level of leverage with a debt-to-equity ratio of 0.58.
    • The company is currently unprofitable, with a net loss and negative returns on equity and assets.
    • The company's liquidity position is medium, with a current ratio of 1.46 and a negative net cash position.
    • The company's growth trajectory is unclear, with no forward-looking revenue projections provided.
    • The company has a low potential for dilution, but its liquidity risk is assessed as medium.
    • margin_outlook_rationale: The company's margin outlook is negative due to its current net loss and negative returns on equity and assets.
    • rd_outlook_rationale: No specific information is available to assess the company's research and development outlook.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $0,09
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $71.4M
    Net cash
    -$36.4M
    Current ratio
    1.5
    Debt / equity
    0.6
    ROA
    -1.7%
    ROE
    -3.3%
    Cash conversion
    -16.0%
    CapEx / revenue
    -5.5%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin0,1 %Below median
    Net Margin-2,0 %Below median
    ROE-3,3 %Below median
    Capex / Rev-5,5 %Below median
    D/E0,58Bottom quartile
    Cash Conv-0,16Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • VICP.SI Market data — financials · 2026-05-29

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    VICP.SICanonical
    SGX · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    • Shareholders' equity (YoY) (2023-12-31 vs 2022-12-31): -102.9%Derived (calculated)
    • Operating cash flow (YoY) (2023-12-31 vs 2022-12-31): -75.3%Derived (calculated)
    • Operating income (YoY) (2023-12-31 vs 2022-12-31): -6.3%Derived (calculated)
    • Total assets (YoY) (2023-12-31 vs 2022-12-31): -44.9%Derived (calculated)
    • R&D expense (YoY) (2023-12-31 vs 2022-12-31): 16.6%Derived (calculated)
    • EPS (diluted) (YoY) (2023-12-31 vs 2022-12-31): 0.0%Derived (calculated)
    • EPS (basic) (YoY) (2023-12-31 vs 2022-12-31): 0.0%Derived (calculated)
    • Return on equity (FY 2023-12-31): 61.3%Derived (calculated)
    • Return on assets (FY 2023-12-31): -2,980.9%Derived (calculated)
    • Current ratio (FY 2023-12-31): 0.02xDerived (calculated)
    • Cash & equivalents (YoY) (2023-12-31 vs 2022-12-31): -33.2%Derived (calculated)
    • Net income (YoY) (2023-12-31 vs 2022-12-31): -20.0%Derived (calculated)
    • Pre-tax income (annual): USD -1.18MSEC XBRL filing
    • R&D expense (annual): USD 15.27KSEC XBRL filing
    • Cash & equivalents (annual): USD 9.42KSEC XBRL filing
    • Current assets (annual): USD 39.66KSEC XBRL filing
    • Operating cash flow (annual): USD -417.52KSEC XBRL filing
    • Shares outstanding (annual): 32.07MSEC XBRL filing
    • Net income (annual): USD -1.18MSEC XBRL filing
    • Total assets (annual): USD 39.66KSEC XBRL filing
    • EPS (basic) (annual): USD-PER-SHARES -0SEC XBRL filing
    • Operating income (annual): USD -1.05MSEC XBRL filing
    • Total operating expenses (annual): USD 1.05MSEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES -0SEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage